76 related articles for article (PubMed ID: 38608099)
1. [Molecular Pathogenesis of Testicular Germ Cell Tumors].
Bakardjieva-Mihaylova V; Škvárová Kramarzová K; Slámová M; Büchler T; Boublíková L
Klin Onkol; 2017; 30(6):412-419. PubMed ID: 29271211
[TBL] [Abstract][Full Text] [Related]
2. Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype.
Greene MH; Kratz CP; Mai PL; Mueller C; Peters JA; Bratslavsky G; Ling A; Choyke PM; Premkumar A; Bracci J; Watkins RJ; McMaster ML; Korde LA
Endocr Relat Cancer; 2010 Jun; 17(2):R109-21. PubMed ID: 20228134
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review.
Li L; Hu Y; Li X; Ju B
Medicine (Baltimore); 2024 Apr; 103(15):e37688. PubMed ID: 38608099
[TBL] [Abstract][Full Text] [Related]
4. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive characterization of cancer-testis genes in testicular germ cell tumor.
Chang Y; Wang X; Xu Y; Yang L; Qian Q; Ju S; Chen Y; Chen S; Qin N; Ma Z; Dai J; Ma H; Jin G; Zhang E; Wang C; Hu Z
Cancer Med; 2019 Jul; 8(7):3511-3519. PubMed ID: 31070303
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA RFPL3S Functions as a Biomarker of Prognostic and Immunotherapeutic Prediction in Testicular Germ Cell Tumor.
Guo J; Wang S; Jiang Z; Tang L; Liu Z; Cao J; Hu Z; Chen X; Luo Y; Bo H
Front Immunol; 2022; 13():859730. PubMed ID: 35669771
[TBL] [Abstract][Full Text] [Related]
7. Identification of new biomarkers in immune microenvironment of testicular germ cell tumour.
Song Y; Qi X; Kang J; Wang X; Ou N; Zhu J; Wang S; Liu X
Andrologia; 2021 Apr; 53(3):e13986. PubMed ID: 33544925
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 (TLR2) is a candidate prognostic factor in testicular germ cell tumors as well as an indicator of immune function in the tumor microenvironment.
Wu H; Zhang Z; Xiao XY; Zhang ZY; Gao SL; Lu C; Zuo L; Zhang LF
Bioengineered; 2021 Dec; 12(1):1939-1951. PubMed ID: 34002664
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
PeerJ; 2023; 11():e15654. PubMed ID: 37520246
[TBL] [Abstract][Full Text] [Related]
10. Machine learning immune-related gene based on KLRB1 model for predicting the prognosis and immune cell infiltration of breast cancer.
Huang G; Xiao S; Jiang Z; Zhou X; Chen L; Long L; Zhang S; Xu K; Chen J; Jiang B
Front Endocrinol (Lausanne); 2023; 14():1185799. PubMed ID: 37351109
[TBL] [Abstract][Full Text] [Related]
11. European Association of Urology Guidelines on Testicular Cancer: 2023 Update.
Patrikidou A; Cazzaniga W; Berney D; Boormans J; de Angst I; Di Nardo D; Fankhauser C; Fischer S; Gravina C; Gremmels H; Heidenreich A; Janisch F; Leão R; Nicolai N; Oing C; Oldenburg J; Shepherd R; Tandstad T; Nicol D
Eur Urol; 2023 Sep; 84(3):289-301. PubMed ID: 37183161
[TBL] [Abstract][Full Text] [Related]
12. CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases.
Gómez-Melero S; Caballero-Villarraso J
Antibodies (Basel); 2023 Apr; 12(2):. PubMed ID: 37092451
[TBL] [Abstract][Full Text] [Related]
13. Management of testicular germ cell tumors.
Wee CE; Gilligan TD
Clin Adv Hematol Oncol; 2023 Apr; 21(4):179-188. PubMed ID: 37039725
[TBL] [Abstract][Full Text] [Related]
14. Structural mechanisms for regulation of GSDMB pore-forming activity.
Zhong X; Zeng H; Zhou Z; Su Y; Cheng H; Hou Y; She Y; Feng N; Wang J; Shao F; Ding J
Nature; 2023 Apr; 616(7957):598-605. PubMed ID: 36991125
[TBL] [Abstract][Full Text] [Related]
15. Testicular germ cell tumors: Genomic alternations and RAS-dependent signaling.
Nakhaei-Rad S; Soleimani Z; Vahedi S; Gorjinia Z
Crit Rev Oncol Hematol; 2023 Mar; 183():103928. PubMed ID: 36717007
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
